Ignite Creation Date:
2024-05-06 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04714658
Status:
NOT_YET_RECRUITING
Last Update Posted:
2021-01-19
First Post:
2020-11-25
Brief Title:
Education Program in Myasthenia
Sponsor:
University Hospital Strasbourg France
Organization:
University Hospital Strasbourg France
Study Overview
Official Title:
Efficiency of a Therapeutic Patient Education Program in Myasthenia Gravis
Status:
NOT_YET_RECRUITING
Status Verified Date:
2020-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MG-ETP
Brief Summary:
Patient therapeutic education PTE has become a must in the modern management of chronic diseases Its main objective is to improve compliance with treatment and the application of preventive measures The main goal of this study is to assess the influence of the therapeutic education program on the perception of the disease in patients with autoimmune myasthenia Secondary objectives are to assess quality of life patient satisfaction of the PTE program the acquisition of therapeutic goals and the influence of therapeutic education on the evolution of autoimmune myasthenia Study team hypothesize that therapeutic education could improve the patients perception of myasthenia and its quality of life By improving patients adherence to treatments and his knowledge of the disease it could also improve the evolution of myasthenia gravis Study team suppose that PTE program can reduce the absenteeism at work the number and duration of hospitalizations particularly those in intensive care units
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None